Immunologic monitoring.

Area of Science:

• Immunology
• Transplantation Science
• Clinical Diagnostics

Background:

• Clinical transplantation requires reliable in vitro assays to quantify and characterize anti-donor alloimmune responses.
• Predicting pre-transplant sensitization and identifying rejection non-invasively are key clinical goals.
• Advancements in transplantation biology and therapeutics enable assays to identify both rejection and tolerance.

Purpose of the Study:

• To review informative in vitro assays for assessing anti-donor alloimmune responses in transplantation.
• To enhance understanding of the mechanisms and timing of graft rejection.
• To evaluate tolerance-inducing strategies and identify tolerant transplant recipients for immunosuppression weaning.

Main Methods:

• Discussion of traditional limiting dilution assays.
• Inclusion of complementary techniques such as ELISpot, flow cytometry, and microarray analysis.
• Review of currently informative assays for alloimmune monitoring.

Main Results:

• The reviewed assays provide insights into the processes of transplant rejection.
• These methods contribute to a better understanding of alloimmune responses.
• Informative assays are essential for evaluating therapeutic strategies and patient monitoring.

Conclusions:

• In vitro assays are vital for predicting transplant rejection and assessing immune tolerance.
• Accurate immunologic monitoring extends beyond transplantation to broader clinical applications.
• The development and application of these assays support personalized immunosuppression management.